Extended follow-up studies would identify any delayed adverse effects and establish whether therapeutic benefits persist, diminish, or require continued treatment for maintenance
Reimbursement remains a challenge: the evidence base is growing but large randomised controlled trials in type 1 diabetes remain limited
Your provider can assess whether glutathione addresses your actual clinical concern or whether other interventionssuch as slower GLP-1 titration, dietary adjustments, or B-vitamin supportmay be more evidence-based for your situation
NX: Supervision, Writing review & editing, Conceptualization, Resources
Gallbladder disease In patients with established gallbladder disease, the relative risks and benefits of a cholecystectomy or preventive treatment with ursodeoxycholic acid before starting GLP-1 receptor agonist therapy should be thoroughly discussed
Stem cells translational medicine